Pages that link to "Q46548791"
Jump to navigation
Jump to search
The following pages link to Functional polymorphism of the human multidrug resistance gene (MDR1) and polydipsia-hyponatremia in schizophrenia (Q46548791):
Displaying 10 items.
- The promise and reality of pharmacogenetics in psychiatry (Q35226451) (← links)
- Influence of ABCB1 genetic polymorphisms on the pharmacokinetics of risperidone in healthy subjects with CYP2D6*10/*10 (Q35287206) (← links)
- Interplay of pharmacogenetic variations in ABCB1 transporters and cytochrome P450 enzymes (Q37964574) (← links)
- Pharmacogenetics of clinical response to risperidone. (Q38074712) (← links)
- Individualizing clozapine and risperidone treatment for schizophrenia patients (Q38170458) (← links)
- Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients (Q41197042) (← links)
- The effects of clozapine on quinpirole-induced non-regulatory drinking and prepulse inhibition disruption in rats (Q42973048) (← links)
- Association study between the MDR1 gene and clinical characteristics in schizophrenia (Q51134921) (← links)
- The Promise and Reality of Pharmacogenetics in Psychiatry (Q51846528) (← links)
- Effect of COMT Val108/158Met genotype on risk for polydipsia in chronic patients with schizophrenia (Q87128625) (← links)